Myostatin inhibitors hold promise for treating a range of muscle-wasting disorders. For instance, in Duchenne muscular dystrophy, a genetic condition characterized by progressive muscle degeneration, myostatin inhibition can potentially slow disease progression and improve muscle function. Similarly, in age-related muscle loss (sarcopenia), myostatin inhibitors could help maintain muscle mass and strength, enhancing quality of life.
